Sign Up for a Free Account
  • Updated 09.02.2019
  • Released 03.30.1994
  • Expires For CME 09.02.2022

Idiopathic intracranial hypertension

Introduction

Overview

Idiopathic intracranial hypertension is characterized by obesity, headaches, nausea, papilledema, transient visual obscurations, and pulsatile tinnitus. Untreated, it can result in optic nerve injury, consequent visual field defects, and blindness. It continues to be a diagnostic and therapeutic challenge, and the incidence is rising as obesity becomes more prevalent. This update reviews its clinical features in adults and children, conditions with which it can be confused, predisposing conditions diagnostic evaluation and criteria, and current therapeutic options.

Key points

• Headaches, transient visual obscurations, and pulsatile tinnitus are the most frequent early manifestations of idiopathic intracranial hypertension in adults.

• Obese women of childbearing age are most commonly affected by idiopathic intracranial hypertension, but the syndrome may occur from secondary causes in children, nonobese patients, and those over 45 years of age.

• The manifestations of idiopathic intracranial hypertension in children differ from those in adults and include asymptomatic papilledema, prominent neck or back pain, diplopia, torticollis, and other focal neurologic signs.

• Visual acuity reduction or significant visual field loss at presentation is an ominous sign, requiring aggressive intervention.

• The Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) provides evidence-based therapy for patients who have mild visual loss.

• A team approach to management is ideal, and a team leader (generally a neurologist or neuro-ophthalmologist) is critical.

Historical note and terminology

In 1897, Quincke first described a syndrome of elevated intracranial pressure and bilateral papilledema due to impaired cerebrospinal fluid circulation. Seven years later, Nonne recognized that this group of conditions mimicked an intracranial tumor and named them "pseudotumor cerebri." In 1937, Dandy suggested that pseudotumor cerebri resulted from increased cerebral blood volume. In 1955, Foley popularized the term "benign intracranial hypertension." Recognition of visual loss as a possible complication resulted in substitution of the descriptor "idiopathic" for "benign" in 1982 (20). The diagnostic criteria were updated in 2002 to reflect advances in neuroimaging techniques and to incorporate atypical presentations (43). Revised criteria in 2013 defined the diagnosis of pseudotumor cerebri syndrome in adults and children, including criteria for those in whom papilledema is absent (44).

“Idiopathic intracranial hypertension” is the term applied when no secondary cause is found, generally in obese women of childbearing age.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, 
including video clips of 
neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of 
neurology in 1,200 
comprehensive articles.

Questions or Comment?

MedLink, LLC

10393 San Diego Mission Rd, Suite 120

San Diego, CA 92108-2134

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com